Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts

Last Updated: January 24, 2020

DrugPatentWatch Database Preview

CONRAY 43 Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Which patents cover Conray 43, and what generic alternatives are available?

Conray 43 is a drug marketed by Liebel-flarsheim and is included in one NDA.

The generic ingredient in CONRAY 43 is iothalamate meglumine. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the iothalamate meglumine profile page.

Drug patent expirations by year for CONRAY 43
Pharmacology for CONRAY 43
Synonyms for CONRAY 43
1-Deoxy-1-(methylamino)-D-glucitol 3-(acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)benzoate
1-Deoxy-1-(methylamino)-D-glucitol 5-acetamido-2,4,6-triiodo-N-methylisophthalamate (salt)
3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid; (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid; 6-(methylamino)hexane-1,2,3,4,5-pentol
3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid;6-(methylamino)hexane-1,2,3,4,5-pentol
Benzoic acid, 3-(acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)-, compd. with 1-deoxy-1-(methylamino)-D-glucitol (1:1)
Conray (TN)
Conray 280
Conray 30
Conray 60
Conray meglumin
Conray meglumine 282
Contrix 28
Cysto-conray II
D-Glucitol, 1-deoxy-1-(methylamino)-, 3-(acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)benzoate (salt)
EINECS 235-998-9
Iotalamate de methylglucamine
Iotalamate de methylglucamine [French]
Iotalamic acid meglumine
Iothalamate meglumine
Iothalamate meglumine (USP)
Iothalamate Meglumine [USAN]
Iothalamate meglumine [USP]
Iothalamate methylglucamine
Iothalamate methylglucamine salt
Iothalamic acid N-methylgucamine salt
Isophthalamic acid, 5-acetamido-2,4,6-triiodo-N-methyl-, compd. with 1-deoxy-1-(methylamino)-D-glucitol (1:1)
Jotalamsaeure methylglucaminesalz
Jotalamsaeure methylglucaminesalz [German]
Meglumine conray
Meglumine iotalamate
Meglumine Iotalamate Injection
Meglumine iotalamate injection (JP17)
Meglumine iothalamate
Meglumine Iothalamate (BAN)
Meglumine Iothalamate [BAN]
Meglumine isothalamate
Methylglucamine iotalamate
Methylglucamine iothalamate

US Patents and Regulatory Information for CONRAY 43

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Liebel-flarsheim CONRAY 43 iothalamate meglumine INJECTABLE;INJECTION 013295-002 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.